Loading clinical trials...
Loading clinical trials...
D-serine Augmentation of Neuroplasticity-based Auditory Learning in Schizophrenia: R33 Phase
Conditions
Interventions
D-serine
Placebo
Locations
1
United States
NYSPI
New York, New York, United States
Start Date
December 1, 2022
Primary Completion Date
April 1, 2027
Completion Date
August 31, 2027
Last Updated
August 5, 2025
NCT06894212
NCT04226898
NCT05240976
NCT06745479
NCT07455929
NCT05304767
Lead Sponsor
New York State Psychiatric Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions